From: Impact of dexamethasone in severe COVID-19-induced acute kidney injury: a multicenter cohort study
Association between dexamethasone use and occurrence of AKI in patients admitted in an ICU for severe COVID-19 infection. Results of cause-specific Cox models | ||
---|---|---|
HR* | 95 CI | |
Dexamethasone use (vs no use): Model 1 | 0.67 | 0.55–0.81 |
Model 2 (Model 1 adjusted for center) | 0.76 | 0.62–0.92 |
Model 3 (Excluding patients with a delay of less than 12 h from the administration of DXM and the AKI) | 0.62 | 0.49–0.77 |
Model 4 (Model 1 adjusted for wave rather than COVID variant) | 0.75 | 0.57–1.00 |